Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Landmark Five-Year African Study Indicates That HIV Therapy May Be Given Safely In Re-Limited Settings Without Routine Laboratory Monitoring
Gilead Sciences, Inc. (Nasdaq:GILD) highlighted results from a study known as DART (Development of Anti-Retroviral Treatment in Africa), which evaluated the need for routine laboratory monitoring in adults taking antiretroviral therapy in Africa. The DART trial was an open-label, randomized study comparing clinical and laboratory monitoring to clinical monitoring alone for efficacy and toxicity. In this study, 74 percent of patients were on a treatment regimen containing Viread® (tenofovir disoproxil fumarate). At baseline, more than 50 percent of patients had reduced renal function. The results indicated that Viread was well tolerated and that the incidence of renal adverse events was low. DART researchers concluded that renal function test results were similar in both arms of the trial for up to five years, suggesting that routine monitoring of Viread may not be necessary in re-limited settings when using the product as part of a first-line HIV treatment regimen. The results of the study were presented today at the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009) in Cape Town, South Africa.
generic viagra online
U.N. Secretary-General, WHO Director-General Appeal For Continued Investment In Global Health
Despite the current global economic crisis, U.N. Secretary-General Ban Ki-moon on Monday called for a continued international commitment to investing in health, Xinhua/People"s Daily reports. "We can cut back on health expenditures and incur massive losses in lives and fundamental capacity for growth. Or we can invest in health and spare both people and economies the high cost of inaction," Ban said during an address at the U.N. Forum on Advancing Global Health in the Face of Crises, a day-long forum at U.N. headquarters in New York. "The cost of cutting back is just unthinkable" (Xinhua/People"s Daily, 6/16).
News of the day
New Study Demonstrates NanoScan's Novel Contrast Agent May Identify Heart Attack In Waiting
NanoScan Imaging, LLC announced the publication of new data demonstrating the use of its investigational, radio-opaque contrast agent (N1177) to visualize vulnerable plaques that can cause heart attack or stroke using advanced, non-invasive and high-resolution computed tomography (CT) techniques. Results of the study were published in the current issue of the peer-reviewed Journal of Nuclear Medicine (J Nucl Med. 2009 Jun;50(6):959-965).
Mental Health

Connecticut Department Of Public Health Implements Plan To Limit The Spread Of Novel H1N1 Influenza In Youth Camps

The Department of Public Health (DPH) announced that it is implementing a plan to limit the spread of novel H1N1 influenza, or swine flu, in youth camps. "The health and wellness of our children is a top priority," stated DPH Commissioner Dr. J. Robert Galvin. "At this time of year, when school is ending and many children are attending camps, it is important that the camps are aware of the seriousness of H1N1 and the best ways to protect the children attending their camps from it." DPH"s plan to limit the spread of novel H1N1 influenza in youth camps includes: - Coordinating with local health departments and licensed camps throughout the state to assist them in addressing the current H1N1 situation while they prepare for the upcoming camp season. - Encouraging camps to develop a working relationship with local health officials and plan jointly for possible contingencies during the camp season. - Encouraging camps to pre-plan with parents/guardians regarding how illnesses or health emergencies among children attending camp will be handled. - Encouraging camps to educate parents and staff about communicable disease prevention including specific information on how to recognize symptoms of influenza-like illness. DPH is recommending guidance recently issued by the Centers for Disease Control and Prevention (CDC) specific to novel H1N1 influenza and camps. In addition, DPH has advised camps of the procedures for reporting outbreaks and disease in a camp setting, and provided camps with an informational letter for parents regarding when to keep their children home from camp. The CDC guidance as well as the materials developed by DPH may be accessed by visiting the Connecticut Flu Watch at http://www.ct.gov/ctfluwatch/swineflu and are posted under the heading "Schools/Daycares/Camps." The Department of Public Health licenses more than 400 youth camps each year. Licensing assures that those programs that are licensed have achieved at least the minimum standards required by law to meet the health, safety and comfort needs of campers and staff. The Connecticut Department of Public Health


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009